Have a personal or library account? Click to login
Interaction of Biochemical Processes between Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension (PAH), and Coronavirus Disease 2019 (COVID-19) Cover

Interaction of Biochemical Processes between Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension (PAH), and Coronavirus Disease 2019 (COVID-19)

By: Zhe Tian and  Lilan Cen  
Open Access
|Jun 2023

References

  1. Aghagoli G, Gallo Marin B, Soliman LB, Sellke FW. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: a review. J Card Surg. 2020 Jun;35(6):1302–1305. https://doi.org/10.1111/jocs.14538
  2. Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS, Quaderi S, Mandal S, Hurst JR. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS One. 2020 May;15(5):e0233147. https://doi.org/10.1371/journal.pone.0233147
  3. Banerjee A, Koziol-White C, Panettieri R Jr. p38 MAPK inhibitors, IKK2 inhibitors, and TNFα inhibitors in COPD. Curr Opin Pharmacol. 2012 Jun;12(3):287–292. https://doi.org/10.1016/j.coph.2012.01.016
  4. Beigel JH, Nam HH, Adams PL, Krafft A, Ince WL, El-Kamary SS, Sims AC. Advances in respiratory virus therapeutics – a meeting report from the 6th isirv Antiviral Group conference. Antiviral Res. 2019 Jul;167:45-67. https://doi.org/10.1016/j.antiviral.2019.04.006
  5. Bhuiyan MN, Ganesh R, Ghosh AK. COVID-19: A 2020 update. Indian J Med Sci. 2020 Aug;72(2):88–94. https://doi.org/10.25259/IJMS_123_2020
  6. Blanco-Melo D, Nilsson-Payant BE, Liu WC, Uhl S, Hoagland D, Møller R, Jordan TX, Oishi K, Panis M, Sachs D, et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020 May;181(5):1036–1045.e9. https://doi.org/10.1016/j.cell.2020.04.026
  7. Cunningham AC, Goh HP, Koh D. Treatment of COVID-19: old tricks for new challenges. Crit Care. 2020 Mar;24(1):91. https://doi.org/10.1186/s13054-020-2818-6
  8. Daamen AR, Bachali P, Owen KA, Kingsmore KM, Hubbard EL, Labonte AC, Robl R, Shrotri S, Grammer AC, Lipsky PE. Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway. Sci Rep. 2021 Mar;11(1):7052. https://doi.org/10.1038/s41598-021-86002-x
  9. Deng Q, Hu B, Zhang Y, Wang H, Zhou X, Hu W, Cheng Y, Yan J, Ping H, Zhou Q. Suspected myocardial injury in patients with COVID-19: evidence from front-line clinical observation in Wuhan, China. Int J Cardiol. 2020 Jul;311:116-121. https://doi.org/10.1016/j.ijcard.2020.03.087
  10. Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther. 2020 Feb;14(1):58–60. https://doi.org/10.5582/ddt.2020.01012
  11. Farha S, Heresi GA. COVID-19 and pulmonary arterial hypertension: Early data and many questions. Ann Am Thorac Soc. 2020 Dec; 17(12):1528–1530. https://doi.org/10.1513/AnnalsATS.202008-1014ED
  12. Gholaminejad A, Fathalipour M, Roointan A. Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm. BMC Nephrol. 2021 Jul;22(1):245. https://doi.org/10.1186/s12882-021-02447-2
  13. Guo S, Yang P, Jiang X, Li X, Wang Y, Zhang X, Sun B, Zhang Y, Jia Y. Genetic and epigenetic silencing of mircoRNA-506-3p enhances COTL1 oncogene expression to foster non-small lung cancer progression. Oncotarget. 2017 Jan;8(1):644–657. https://doi.org/10.18632/oncotarget.13501
  14. Heinbockel L, Marwitz S, Schromm AB, Watz H, Kugler C, Ammerpohl O, Schnepf K, Rabe KF, Droemann D, Goldmann T. Identification of novel target genes in human lung tissue involved in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2018 Jul;13:2255-2259. https://doi.org/10.2147/COPD.S161958
  15. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004 Jun;350(26):2645–2653. https://doi.org/10.1056/NEJMoa032158
  16. Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2020 Jul–Aug;14(4):395–403. https://doi.org/10.1016/j.dsx.2020.04.018
  17. Irving AT, Zhang Q, Kong PS, Luko K, Rozario P, Wen M, Zhu F, Zhou P, Ng JHJ, Sobota RM, et al. Interferon regulatory factors IRF1 and IRF7 directly regulate gene expression in bats in response to viral infection. Cell Rep. 2020 Nov;33(5):108345. https://doi.org/10.1016/j.celrep.2020.108345
  18. Kaner RJ, Ladetto JV, Singh R, Fukuda N, Matthay MA, Crystal RG. Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am J Respir Cell Mol Biol. 2000 Jun;22(6):657–664. https://doi.org/10.1165/ajrcmb.22.6.3779
  19. Lazear HM, Schoggins JW, Diamond MS. Shared and distinct functions of type I and type III interferons. Immunity. 2019 Apr;50(4): 907–923. https://doi.org/10.1016/j.immuni.2019.03.025
  20. Leng L, Cao R, Ma J, Mou D, Zhu Y, Li W, Lv L, Gao D, Zhang S, Gong F, et al. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples. Signal Transduct Target Ther. 2020 Oct;5(1):240. https://doi.org/10.1038/s41392-020-00355-9
  21. Leung JM, Yang CX, Tam A, Shaipanich T, Hackett TL, Singhera GK, Dorscheid DR, Sin DD. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. Eur Respir J. 2020 May;55(5):2000688. https://doi.org/10.1183/13993003.00688-2020
  22. Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov. 2020 Mar;19(3):149–150. https://doi.org/10.1038/d41573-020-00016-0
  23. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014 Dec;15(12):550. https://doi.org/10.1186/s13059-014-0550-8
  24. Manne BK, Denorme F, Middleton EA, Portier I, Rowley JW, Stubben C, Petrey AC, Tolley ND, Guo L, Cody M, et al. Platelet gene expression and function in patients with COVID-19. Blood. 2020 Sep;136(11):1317–1329. https://doi.org/10.1182/blood.2020007214
  25. Marson A, Levine SS, Cole MF, Frampton GM, Brambrink T, Johnstone S, Guenther MG, Johnston WK, Wernig M, Newman J, et al. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell. 2008 Aug;134(3): 521–533. https://doi.org/10.1016/j.cell.2008.07.020
  26. Mishra A, Lal A, Sahu KK, George AA, Martin K, Sargent J. An update on pulmonary hypertension in Coronavirus Disease-19 (COVID-19). Acta Biomed. 2020 Nov;91(4):e2020155. https://doi.org/10.23750/abm.v91i4.10698
  27. Oh KK, Adnan M, Cho DH. Network pharmacology approach to decipher signaling pathways associated with target proteins of NSAIDs against COVID-19. Sci Rep. 2021 May;11(1):9606. https://doi.org/10.1038/s41598-021-88313-5
  28. Ovali F. SARS-CoV-2 Infection and the Newborn. Front Pediatr. 2020 May;8:294. https://doi.org/10.3389/fped.2020.00294
  29. Pang J, Xu F, Aondio G, Li Y, Fumagalli A, Lu M, Valmadre G, Wei J, Bian Y, Canesi M, et al. Efficacy and tolerability of bevacizumab in patients with severe Covid-19. Nat Commun. 2021 Feb; 12(1):814. https://doi.org/10.1038/s41467-021-21085-8
  30. Park J, Lee SH, You SC, Kim J, Yang K. Non-steroidal anti-inflammatory agent use may not be associated with mortality of coronavirus disease 19. Sci Rep. 2021 Mar;11(1):5087. https://doi.org/10.1038/s41598-021-84539-5
  31. Reddy NM, Vegiraju S, Irving A, Paun BC, Luzina IG, Atamas SP, Biswal S, Ana NA, Mitzner W, Reddy SP. Targeted deletion of Jun/AP-1 in alveolar epithelial cells causes progressive emphysema and worsens cigarette smoke-induced lung inflammation. Am J Pathol. 2012 Feb;180(2):562–574. https://doi.org/10.1016/j.ajpath.2011.10.029
  32. Rusmini M, Uva P, Amoroso A, Tolomeo M, Cavalli A. How genetics might explain the unusual link between malaria and COVID-19. Front Med. 2021 Apr;8:650231. https://doi.org/10.3389/fmed.2021.650231
  33. Saheb Sharif-Askari N, Saheb Sharif-Askari F, Alabed M, Temsah MH, Al Heialy S, Hamid Q, Halwani R. Airways expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 is lower in children than adults and increases with smoking and COPDMol Ther Methods Clin Dev. 2020 May 22;18:1–6. https://doi.org/10.1016/j.omtm.2020.05.013
  34. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003 Nov;13(11):2498–2504. https://doi.org/10.1101/gr.1239303
  35. Sheahan TP, Sims AC, Leist SR, Schäfer A, Won J, Brown AJ, Montgomery SA, Hogg A, Babusis D, Clarke MO, et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun. 2020 Jan;11(1):222. https://doi.org/10.1038/s41467-019-13940-6
  36. Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S, Bork P, Jensen LJ, von Mering C. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023 Jan; 51(D1):D638–D646. https://doi.org/10.1093/nar/gkac1000
  37. Tang X, Luo Y, Song Y, Fan H, Dong S, Liu P, Chen Y. Neurological manifestations in COVID-19 and its possible mechanism. Aging (Albany NY). 2020 Sep;12(18):18754–18764. https://doi.org/10.18632/aging.103732
  38. Tudoran C, Tudoran M, Lazureanu VE, Marinescu AR, Pop GN, Pescariu AS, Enache A, Cut TG. Evidence of pulmonary hypertension after SARS-CoV-2 infection in subjects without previous significant cardiovascular pathology. J Clin Med. 2021 Jan;10(2):199. https://doi.org/10.3390/jcm10020199
  39. Verma S, Twilley D, Esmear T, Oosthuizen CB, Reid AM, Nel M, Lall N. Anti-SARS-CoV natural products with the potential to inhibit SARS-CoV-2 (COVID-19). Front Pharmacol. 2020 Sep;11: 561334. https://doi.org/10.3389/fphar.2020.561334
  40. Vicenzi M, Ruscica M, Iodice S, Rota I, Ratti A, Di Cosola R, Corsini A, Bollati V, Aliberti S, Blasi F. The efficacy of the mineralcorticoid receptor antagonist canrenone in COVID-19 patients. J Clin Med. 2020 Sep;9(9):2943. https://doi.org/10.3390/jcm9092943
  41. Wei H, Zhang D, Liu L, Xia W, Li F. Rho signaling pathway enhances proliferation of PASMCs by suppressing nuclear translocation of Smad1 in PAH. Exp Ther Med. 2019 Jan;17(1):71–78. https://doi.org/10.3892/etm.2018.6942
  42. Wen W, Su W, Tang H, Le W, Zhang X, Zheng Y, Liu X, Xie L, Li J, Ye J, et al. Author Correction: immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 2020 Jun;6:41. https://doi.org/10.1038/s41421-020-00187-5
  43. White K, Loughlin L, Maqbool Z, Nilsen M, McClure J, Dempsie Y, Baker AH, MacLean MR. Serotonin transporter, sex, and hypoxia: microarray analysis in the pulmonary arteries of mice identifies genes with relevance to human PAH. Physiol Genomics. 2011 Apr;43(8):417–437. https://doi.org/10.1152/physiolgenomics.00249.2010
  44. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr;323(13):1239–1242. https://doi.org/10.1001/jama.2020.2648
  45. Xie Z, Bailey A, Kuleshov MV, Clarke DJ, Evangelista JE, Jenkins SL, Lachmann A, Wojciechowicz ML, Kropiwnicki E, Jagodnik KM, et al. Gene set knowledge discovery with enrichr. Curr Protoc. 2021 Mar;1(3):e90. https://doi.org/10.1002/cpz1.90
  46. Yan R, Zhang F, Rao X, Lv Z, Li J, Zhang L, Liang S, Li Y, Ren F, Zheng C, et al. Richer fusion network for breast cancer classification based on multimodal data. BMC Med Inform Decis Mak. 2021 Apr;21(Suppl 1):134. https://doi.org/10.1186/s12911-020-01340-6
  47. Yi K, Rong Y, Wang C, Huang L, Wang F. COVID-19: advance in laboratory diagnostic strategy and technology. Mol Cell Biochem. 2021 Mar;476(3):1421–1438. https://doi.org/10.1007/s11010-020-04004-1
  48. Yoo M, Shin J, Kim J, Ryall KA, Lee K, Lee S, Jeon M, Kang J, Tan AC. DSigDB: drug signatures database for gene set analysis. Bioinformatics. 2015 Sep;31(18):3069–3071. https://doi.org/10.1093/bioinformatics/btv313
  49. Zhang F, Gan R, Zhen Z, Hu X, Li X, Zhou F, Liu Y, Chen C, Xie S, Zhang B, et al. Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals. Signal Transduct Target Ther. 2020a Aug;5(1):156. https://doi.org/10.1038/s41392-020-00263-y
  50. Zhang J, Dong J, Martin M, He M, Gongol B, Marin TL, Chen L, Shi X, Yin Y, Shang F, et al. AMP-activated protein kinase phosphorylation of angiotensin-converting enzyme 2 in endothelium mitigates pulmonary hypertension. Am J Respir Crit Care Med. 2018 Aug; 198(4):509–520. https://doi.org/10.1164/rccm.201712-2570OC
  51. Zhang T, Kawaguchi N, Tsuji K, Hayama E, Furutani Y, Sugiyama H, Nakanishi T. Silibinin upregulates CXCR4 expression in cultured bone marrow cells (BMCs) especially in pulmonary arterial hypertension rat model. Cells. 2020b May;9(5): 1276. https://doi.org/10.3390/cells9051276
DOI: https://doi.org/10.33073/pjm-2023-015 | Journal eISSN: 2544-4646 | Journal ISSN: 1733-1331
Language: English
Page range: 143 - 154
Submitted on: Jan 17, 2023
|
Accepted on: Feb 27, 2023
|
Published on: Jun 14, 2023
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2023 Zhe Tian, Lilan Cen, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.